share_log

HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $10

Benzinga ·  Aug 28, 2023 18:26

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and lowers the price target from $15 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment